ANTIANGINAL AGENT Russian patent published in 2003 - IPC

Abstract RU 2200026 C2

FIELD: medicine, cardiology, pharmacy. SUBSTANCE: invention relates to application of dalargin as an antianginal preparation. The proposed agent allows to enhance effectiveness of treatment and tolerance to physical loadings. Invention can be used for treatment of heart ischemic disease. EFFECT: enhanced effectiveness of treatment. 1 cl, 2 tbl, 2 ex

Similar patents RU2200026C2

Title Year Author Number
METHOD FOR TREATING THE PATIENTS SUFFERING FROM CARDIAC ISCHEMIA DISEASE 1997
  • Karpov R.S.
  • Zamotrinskij A.V.
  • Chernjavskij A.M.
  • Afanas'Ev S.A.
RU2163797C2
METHOD FOR DIAGNOSING THE CASES OF CHRONIC CARDIAC ISCHEMIA DISEASE 2001
  • Tepljakov A.T.
  • Telkova I.L.
RU2200951C2
METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS 1999
  • Markov V.A.
  • Maksimov I.V.
RU2189173C2
METHOD FOR EVALUATING EFFICIENCY OF TREATING HEART'S ISCHEMIC DISEASE 1994
  • Mordovin V.F.
  • Lishmanov Ju.B.
  • Triss S.V.
  • Fedorova N.A.
  • Chernov V.I.
  • Karpov R.S.
RU2104523C1
METHOD FOR APPLYING SECONDARY PROPHYLAXIS OF MYOCARDIAL ISCHEMIA IN EARLY PHYSICAL REHABILITATION OF MYOCARDIAL INFARCTION PATIENTS 1998
  • Borodina L.M.
  • Shalaev S.V.
  • Kazemov V.V.
RU2154401C2
METHOD OF DIAGNOSING EARLY STAGE OF FIRST PHASE OF DISSEMINATED INTRAVASCULAR BLOOD COAGULATION SYNDROME IN CASE OF ISCHEMIA 1991
  • Tukhvatulin R.T.
  • Kanskaja N.V.
  • Karpov R.S.
  • Plekhanov G.F.
RU2012886C1
METHOD FOR APPLYING REPERFUSION THERAPY TO ACUTE MYOCARDIAL INFARCTION PATIENTS 2002
  • Markov V.A.
  • Afanas'Ev S.A.
  • Maksimov I.V.
  • Bujmov G.A.
RU2226097C2
METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC DISEASE TREATMENT 1995
  • Kanskaja N.V.
  • Karpov R.S.
  • Bajkov A.N.
  • Lankin V.Z.
  • Studnitskij V.B.
  • Gridneva T.D.
  • Perova N.V.
RU2122732C1
METHOD FOR CARRYING OUT EARLY PHYSICAL REHABILITATION OF CARDIAC ISCHEMIA PATIENTS 1998
  • Borodina L.M.
  • Shalaev S.V.
RU2154460C2
METHOD FOR SETTING DILTIAZEM DOSE FOR TREATMENT OF PATIENTS WITH POST-INFARCT CARDIOSCLEROSIS AND CIRCULATION INSUFFICIENCY OF FUNCTIONAL CLASS 2 2003
  • Tepljakov A.T.
  • Mamchur S.E.
  • Vovchenko I.A.
RU2255740C2

RU 2 200 026 C2

Authors

Maslov L.N.

Lishmanov Ju.B.

Karpov R.S.

Lasukova T.V.

Fedorova N.A.

Dates

2003-03-10Published

2001-04-09Filed